Stages I-II/ Anal Cancer News

Share


Recent Stages I-II/ Anal Cancer News


New Breakthrough May Advance Triple Negative Breast Cancer Treatment (May 30, 2016)

By Helen Young Scientists at The Scripps Research Institute have developed a new drug candidate that lowers the growth rate of tumor cells in animal models1 in one of the most difficult cancers to battle:... Continue Reading

Can’t Lose Weight? You May Have Some Carb Intolerance (May 27, 2016)

Can’t lose weight? You may have some carb intolerance. By Jackie Buell, RD If you made yet another resolution to lose weight in the New Year, you’re certainly not alone. It is estimated that only... Continue Reading

Novel Immunotherapy Trial for Lymphoma Offers Hope to Patients at Sylvester (May 27, 2016)

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine are testing a novel cellular immunotherapy approach to treating patients with diffuse large B-cell... Continue Reading

New Treatment May Reduce Precancerous Polyps in Both Large and Small Intestine in Hereditary Cancer Patients (May 26, 2016)

A new study published in the Journal of the American Medical Association (JAMA), has reported a new prevention treatment for individuals at high risk of developing colon cancer due to the APC (adenomatous... Continue Reading

Ask the Lynch Syndrome Expert: Q&A Now Available! (May 26, 2016)

CancerConnect Presents: Ask the Expert with Dana-Farber Cancer Institute’s Dr. Perez Lynch Syndrome: Get the Facts about this Hereditary Cancer Syndrome Kimberly Perez, MD CancerConnect announces the... Continue Reading

More Evidence that PD-1 Inhibitors Improve Survival in Head and Neck Cancer (May 25, 2016)

Results from a recent large trial indicate that treatment with the immunotherapy agent Opdivo® (nivolumab) nearly doubles the survival rate at one year in patients with advanced head and neck squamous... Continue Reading

Counsyl Announces Major Oncology Expansion to Advance Genetic Screening for Cancer Risk (May 25, 2016)

Counsyl launches oncology business unit, an expanded test to assess risk for inherited forms of cancer, and tools to improve genetic screening rates across the healthcare system Counsyl, a DNA testing... Continue Reading

Next Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS